Shopping Cart
- Remove All
- Your shopping cart is currently empty
Enfortumab vedotin-ejfv (Padcev) is an ADC compound targeting Nectin-4 with anti-tumor activity, used in the study of urothelial carcinoma.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $835 | In Stock | |
5 mg | $2,430 | In Stock | |
10 mg | $3,290 | In Stock | |
25 mg | $4,880 | In Stock | |
50 mg | $6,590 | In Stock |
Description | Enfortumab vedotin-ejfv (Padcev) is an ADC compound targeting Nectin-4 with anti-tumor activity, used in the study of urothelial carcinoma. |
In vitro | Enfortumab vedotin-ejfv is a fully human IgG1-kappa antibody linked to the microtubule-disrupting monomethyl auristatin E (MMAE) through a protease-cleavable maleimidocaproyl-valine-citrulline linker (SGD-1006) [2]. |
Cas No. | 1346452-25-2 |
Storage | store at low temperature | store at -80°C | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.